R. Jacob Vogelstein, Ph.D.

Co-Founder & Managing Partner at Catalio Capital Management

View Live Interactive Profile →

Biography

R. Jacob Vogelstein is Co-Founder and Managing Partner of Catalio Capital Management, LP, where the firm states he is primarily responsible for managing the firm and for making investments in private innovative healthcare companies. He holds a B.Sc. in Bio-Electrical Engineering from Brown University and a Ph.D. in Biomedical Engineering from the Johns Hopkins University School of Medicine, and was previously a General Partner at Camden Partners Holdings, LLC and a faculty member at Johns Hopkins. He has received the Presidential Early Career Award in Science and Engineering. Directorships at Iambic Therapeutics, NextPoint Therapeutics and Pheast Therapeutics are confirmed by those issuers' own Form D filings; further seats listed on his firm biography at Rhapsogen, Syndeio, Clasp and Winnow Therapeutics could not be confirmed from issuer filings.

Education

• B.Sc. in Bio-Electrical Engineering, Brown University
• Ph.D. in Biomedical Engineering, Johns Hopkins University School of Medicine

Previous Experience

• General Partner, Camden Partners Holdings, LLC
• Faculty member, Johns Hopkins University Applied Physics Laboratory and Whiting School of Engineering

Notable Investments

Board Seats

• Director, Iambic Therapeutics, Inc.
• Director, NextPoint Therapeutics, Inc.
• Director, Pheast Therapeutics, Inc.

Career Timeline

Sources & References